Management of asymptomatic patients on follow-up for ovarian cancer with rising CA-125 concentrations
- 1 September 2007
- journal article
- review article
- Published by Elsevier BV in The Lancet Oncology
- Vol. 8 (9), 813-821
- https://doi.org/10.1016/s1470-2045(07)70273-5
Abstract
No abstract availableKeywords
This publication has 47 references indexed in Scilit:
- Cancer of the OvaryNew England Journal of Medicine, 2004
- Molecular Cloning of the CA125 Ovarian Cancer AntigenPublished by Elsevier BV ,2001
- The CA 125 Gene: An Extracellular Superstructure Dominated by Repeat SequencesTumor Biology, 2001
- CA 125: The past and the FutureThe International Journal of Biological Markers, 1998
- Specificity and Affinity of 26 Monoclonal Antibodies against the CA 125 Antigen: First Report from the ISOBM TD-1 WorkshopTumor Biology, 1996
- The Second Generation CA125 AssaysAnnals of Medicine, 1995
- A Radioimmunoassay Using a Monoclonal Antibody to Monitor the Course of Epithelial Ovarian CancerNew England Journal of Medicine, 1983
- Tissue Distribution of a Coelomic- Epithelium-Related Antigen Recognized by the Monoclonal Antibody OC125International Journal of Gynecological Pathology, 1983
- Immunopathologic Characterization of a Monoclonal Antibody that Recognizes Common Surface Antigens of Human Ovarian Tumors of Serous, Endometrioid, and Clear Cell TypesAmerican Journal of Clinical Pathology, 1983
- Reactivity of a monoclonal antibody with human ovarian carcinoma.JCI Insight, 1981